Harnessing the immune system to treat cancer
Immune therapy remains one of the most exciting areas in clinical cancer research. Maurice Wilkins Centre investigators have discovered several immune modulating drugs and vaccines that are now undergoing preclinical development.
The Maurice Wilkins Centre continues to develop new approaches to immune therapy of cancer, testing them in preclinical models in preparation for clinical trials. Therapeutic modalities under development include self-adjuvanting peptide vaccines, tumour-selective immune activators, inhibitors of immune suppression, and immune cell therapy.
At the same time, investigation of the microenvironment of human cancers aims to discover new targets for immune therapy.